CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Dr Mitsu Ikura
Robert L. Noble Prize recipient in 2010
Dr Ikura is an internationally recognized authority in the field of structural biology and has laid the groundwork for our understanding of signalling proteins such as cadherins and catenins and molecular signalling processes involved in human diseases such as cancer. His studies also provide excellent platforms for developing new drugs designed to interfere with the functioning of cancer cells.
Dr Ikura is a senior scientist at the Ontario Cancer Institute and a professor at the University of Toronto. He received his PhD in macromolecular biophysics from Hokkaido University, Japan and pursued postdoctoral studies on multi-dimensional NMR spectroscopy of a calmodulin-kinase peptide complex at the National Institutes of Health.
Dr Ikura has a Tier-1 Canada Research Chair in cancer structural biology and has been recognized by many awards and prizes including the William E. Rawls Prize, the International Research Scholar Award Howard Hughes Medical Institute, and the Premier’s Research Excellence Award.
He has published over 190 peer-reviewed papers and has been invited to speak at more than 200 international scientific conferences.